Blue Trust Inc’s Sana Biotechnology SANA Stock Holding History

Blue Trust Inc’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.32K	Sell	3,235 -1,481	-31%	-$5.83K	﹤0.01%	1859
2025 Q4	$19.2K	Sell	4,716 -1,790	-28%	-$8.02K	﹤0.01%	1694
2025 Q3	$23.1K	Sell	6,506 -13,014	-67%	-$47K	﹤0.01%	1623
2025 Q2	$53.3K	Sell	19,520 -6,397	-25%	-$13.2K	﹤0.01%	1441
2025 Q1	$43.5K	Sell	25,917 -13,910	-35%	-$38.9K	﹤0.01%	1433
2024 Q4	$64.9K	Buy	39,827 +26,698	+203%	+$79.6K	﹤0.01%	1126
2024 Q3	$71.7K	Buy	13,129 +12,154	+1,247%	+$63.9K	﹤0.01%	1402
2024 Q2	$9.75K	Buy	+975	New	+$7.77K	﹤0.01%	1934

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Blue Trust Inc's SANA Position: Q1 2026 in Review

Blue Trust Inc reduced its Sana Biotechnology (SANA) stake by 31% in Q1 2026, selling an estimated $5.83K and leaving 3,235 shares worth $9.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

Blue Trust Inc first reported a position in SANA in Q2 2024 and has held it in 8 quarters since. The position peaked at $71.7K in Q3 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Blue Trust Inc held 3,235 shares of Sana Biotechnology worth $9.32K as of Q1 2026.
Blue Trust Inc sold 1,481 Sana Biotechnology shares in Q1 2026, an estimated $5.83K.
Sana Biotechnology made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #1859 holding.
Blue Trust Inc first reported a position in Sana Biotechnology in Q2 2024 and has held it in 8 quarters since.
Blue Trust Inc's Sana Biotechnology position peaked at $71.7K in Q3 2024.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.